Consolidated Portfolio Review Corp’s Vanguard S&P Mid-Cap 400 Growth ETF IVOG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,936
Closed -$351K 218
2025
Q3
$351K Sell
2,936
-20
-0.7% -$2.34K 0.04% 335
2025
Q2
$334K Sell
2,956
-35
-1% -$3.72K 0.05% 330
2025
Q1
$309K Hold
2,991
0.05% 292
2024
Q4
$337K Buy
+2,991
New +$351K 0.05% 278

Other funds holding IVOG

Consolidated Portfolio Review Corp's IVOG Position: Q4 2025 in Review

Consolidated Portfolio Review Corp sold out of Vanguard S&P Mid-Cap 400 Growth ETF (IVOG) in Q4 2025, closing a stake of 2,936 shares — an estimated $351K sold.

Consolidated Portfolio Review Corp first reported a position in IVOG in Q4 2024 and held it in 4 quarters. The position peaked at $351K in Q3 2025. 172 funds tracked by Wall St. Rank hold IVOG as of Q4 2025.

  • Consolidated Portfolio Review Corp reported no remaining Vanguard S&P Mid-Cap 400 Growth ETF position as of Q4 2025 after selling out during the quarter.
  • Consolidated Portfolio Review Corp sold 2,936 Vanguard S&P Mid-Cap 400 Growth ETF shares in Q4 2025, an estimated $351K.
  • Consolidated Portfolio Review Corp first reported a position in Vanguard S&P Mid-Cap 400 Growth ETF in Q4 2024 and held it in 4 quarters.
  • Consolidated Portfolio Review Corp's Vanguard S&P Mid-Cap 400 Growth ETF position peaked at $351K in Q3 2025.
  • 172 funds tracked by Wall St. Rank held Vanguard S&P Mid-Cap 400 Growth ETF as of Q4 2025.

Based on Consolidated Portfolio Review Corp's 13F filing for Q4 2025, filed 26 Jan 2026.